PCSA
Processa Pharmaceuticals, Inc.Company with tickers: PCSA
CIK
1533743
CUSIP
74275C403
Shares Outstanding
2,750,173
13F Activity (30d)
6 filings
6 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-14 | — | |
| 8-K | 2020-02-13 | — | |
| 8-K | 2020-02-25 | — | |
| 8-K | 2020-03-05 | — | |
| 10-K | 2020-03-06 | 2019-12-31 | |
| 8-K | 2020-03-17 | — | |
| 8-K | 2020-03-30 | — | |
| 10-Q | 2020-05-15 | 2020-03-31 | |
| 8-K | 2020-05-28 | 2020-05-27 | |
| 8-K | 2020-06-01 | — | |
| 10-Q | 2020-08-05 | 2020-06-30 | |
| 8-K | 2020-08-20 | — | |
| 8-K | 2020-08-27 | 2020-08-23 | |
| 8-K | 2020-10-06 | 2020-10-01 | |
| 8-K | 2020-10-13 | 2020-10-06 | |
| 8-K | 2020-11-05 | 2020-11-03 | |
| 10-Q | 2020-11-12 | 2020-09-30 | |
| 8-K | 2021-01-11 | — | |
| 8-K | 2021-02-18 | 2021-02-16 | |
| 8-K | 2021-03-25 | — | |
| 10-K | 2021-03-25 | 2020-12-31 | |
| 10-K/A | 2021-04-07 | 2020-12-31 | |
| 8-K | 2021-05-13 | — | |
| 10-Q | 2021-05-13 | 2021-03-31 | |
| 8-K | 2021-05-20 | — | |
| 8-K | 2021-05-26 | 2021-05-25 | |
| 8-K | 2021-06-09 | — | |
| 8-K | 2021-06-10 | — | |
| 8-K | 2021-06-17 | 2021-06-16 | |
| 8-K | 2021-07-15 | — | |
| 8-K | 2021-07-30 | 2021-07-29 | |
| 10-Q | 2021-08-12 | 2021-06-30 | |
| 8-K | 2021-08-13 | 2021-08-12 | |
| 8-K | 2021-08-20 | — | |
| 8-K | 2021-09-20 | — | |
| 8-K | 2021-11-05 | 2021-11-03 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| 8-K | 2022-01-06 | 2022-01-01 | |
| 8-K | 2022-01-26 | — | |
| 8-K | 2022-03-17 | — | |
| 8-K | 2022-03-24 | 2022-03-23 | |
| 10-K | 2022-03-30 | 2021-12-31 | |
| 10-K/A | 2022-05-02 | 2021-12-31 | |
| 10-Q | 2022-05-12 | 2022-03-31 | |
| 8-K | 2022-05-12 | — | |
| 8-K | 2022-05-16 | — | |
| 8-K | 2022-07-14 | 2022-07-11 | |
| 8-K | 2022-07-25 | 2022-07-19 | |
| 8-K | 2022-08-04 | — | |
| 10-Q | 2022-08-11 | 2022-06-30 |
Showing 1–50 of 130 filings